AMGN enters the final stretch of August with a notable split: the stock has extended its post-earnings rally while the analyst community is rushing to catch up — and options traders have quietly turned more defensive.
The Street upgrade cycle is the clearest story this week. A wave of target-price increases followed the August 4 earnings beat, and that wave has continued into this week. Argus Research lifted its target to $460 yesterday, maintaining a Buy. Mizuho and Cantor Fitzgerald both raised their targets — to $352 and $400 respectively — while holding Neutral ratings. Earlier in the week, Citigroup moved to $405 from $345 and Barclays to $380 from $360, both keeping neutral-leaning ratings intact. The pattern is consistent: bulls are stretching targets toward $440–$460 (UBS and TD Cowen both raised to that range last week), while the neutral camp is acknowledging the rally but stopping well short of endorsing the current price. The consensus mean target sits at $387, now roughly 9% below Tuesday's close of $425. The stock has run past what most of the Street is willing to formally endorse.
Options positioning has shifted in a direction that deserves attention. The put/call ratio climbed to 1.006 — the highest reading in at least a month and well above its 20-day average of 0.896. The z-score of 1.68 places this close to the top of the distribution without being extreme. For context, the PCR was hovering around 0.80 through most of July; the move higher has been steady since early August and accelerated this week. That points to more active demand for downside protection, even as the stock continues to add ground.
Short interest tells a calmer story. Bears have actually been trimming exposure: short interest as a percentage of float fell from roughly 2.6% in mid-July to 2.4% now, down about 2% on the week. The lending market remains wide open — availability is deep, with shares to borrow far exceeding current demand — and cost to borrow, while up 18% on the week to 0.46%, is still near the floor in absolute terms. There is no meaningful squeeze dynamic here. Shorts are not pressing; if anything, the short score of 36.7 (edging lower over the past week) suggests bearish conviction is fading rather than building. The short score rank at the 60th percentile — flagged in the previous note — has held roughly steady, consistent with modest rather than aggressive bear positioning.
The month-long surge of 16% has re-rated the valuation. The P/E has expanded by nearly 1.5 turns over thirty days to 17.5x, and price-to-book is up almost a full turn to 17.7x. The EPS momentum factor sits at the 67th percentile on a 30-day basis, reflecting the post-earnings estimate revisions, though the EPS surprise rank at the 33rd percentile is a reminder that beats are not a given. The dividend factor scores near the top of the universe at the 99th percentile — the yield component remains durable even as the stock price has risen. Among correlated peers, ABBV had the strongest week at +3.5%, while VRTX and BMRN lagged, with BMRN sliding 3.7%. AMGN's 2.7% weekly gain tracks close to the peer group median, suggesting the move is sector-driven rather than idiosyncratic.
The institutional register shows the large passive holders — BlackRock, Vanguard, State Street — all adding modestly in recent months, with no unusual concentration shifts. On the insider side, a cluster of SVP-level sells hit in early-to-mid August at prices between $402 and $416, typical of option-exercise related selling into a rallying stock rather than a conviction change. The net 90-day insider position is marginally positive in share terms, but the individual transactions are low-significance and routine in nature.
With the next earnings event not until November 5, the dominant near-term question is whether the analyst consensus — currently trailing the stock by roughly 9% — starts to converge upward, or whether the put/call signal reflects a market starting to weigh that gap more seriously.
See the live data behind this article on ORTEX.
Open AMGN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
